Drug Detail:Zavegepant nasal (Zavegepant nasal)
Drug Class: CGRP inhibitors
Drug Detail:Zavegepant nasal (Zavegepant nasal)
Drug Class: CGRP inhibitors
There is no published experience with zavegepant during breastfeeding. Zavegepant is 90% protein bound, so levels in milk are likely low. If zavegepant is required by the mother of an older infant, it is not a reason to discontinue breastfeeding, but until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Relevant published information was not found as of the revision date.
Relevant published information was not found as of the revision date.
Eletriptan, Rizatriptan, Sumatriptan, Zolmitriptan
Zavegepant
1337918-83-8
Breast Feeding
Lactation
Milk, Human
Analgesics
Calcitonin Gene-Related Peptide Receptor Antagonists
CGRP-R Inhibitors
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.